KUUR THERAPEUTICS

kuur-therapeutics-logo

Kuur Therapeutics is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of cytotoxic T cells, called natural killer T cells (NKT cells) and innovative CAR construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors.

#SimilarOrganizations #People #Financial #Event #Website #More

KUUR THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2005-01-01

Address:
London, England, United Kingdom

Country:
United Kingdom

Website Url:
http://www.kuurtx.com

Total Employee:
51+

Status:
Active

Contact:
44 20 7554 4070

Email Addresses:
[email protected]

Total Funding:
191.84 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Content Delivery Network Amazon OpenResty AdBlock Acceptable Ads Bodis DNS


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

piqur-therapeutics-logo

PIQUR Therapeutics

PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.


Current Advisors List

nigel-burns_image

Nigel Burns Board of Directors @ Kuur Therapeutics
Board_member

maina-bhaman_image

Maina Bhaman Board of Directors @ Kuur Therapeutics
Board_member

julia-gregory_image

Julia Gregory Board Member @ Kuur Therapeutics
Board_member
2018-06-01

Current Employees Featured

kevin-boyle_image

Kevin Boyle
Kevin Boyle Chief Executive Officer @ Kuur Therapeutics
Chief Executive Officer
2020-01-01

gregg-sando_image

Gregg Sando
Gregg Sando Founder & former Chief Executive Officer @ Kuur Therapeutics
Founder & former Chief Executive Officer
2006-01-01

thomas-hecht_image

Thomas Hecht
Thomas Hecht Chairman @ Kuur Therapeutics
Chairman

Founder


gregg-sando_image

Gregg Sando

Acquisitions List

Date Company Article Price
2017-06-20 CGT Catapult CGT Catapult acquired by Kuur Therapeutics N/A
2016-07-12 Delenex Therapeutics Delenex Therapeutics acquired by Kuur Therapeutics N/A

Investors List

hambroperksltd_image

Hambro Perks Ltd.

Hambro Perks Ltd. investment in Secondary Market - Kuur Therapeutics

invesco-perpetual-2_image

Invesco Perpetual

Invesco Perpetual investment in Series C - Kuur Therapeutics

touchstoneinnovations_image

Touchstone Innovations

Touchstone Innovations investment in Series C - Kuur Therapeutics

woodford-investment-management_image

Woodford Investment Management

Woodford Investment Management investment in Series C - Kuur Therapeutics

imperial-innovations_image

Imperial Innovations

Imperial Innovations investment in Series B - Kuur Therapeutics

invesco-perpetual_image

Invesco

Invesco investment in Series B - Kuur Therapeutics

woodford-investment-management_image

Woodford Investment Management

Woodford Investment Management investment in Series B - Kuur Therapeutics

wellcome-trust_image

Wellcome Trust

Wellcome Trust investment in Venture Round - Kuur Therapeutics

invesco-perpetual_image

Invesco

Invesco investment in Venture Round - Kuur Therapeutics

imperial-innovations_image

Imperial Innovations

Imperial Innovations investment in Venture Round - Kuur Therapeutics

Official Site Inspections

http://www.kuurtx.com Semrush global rank: 6.43 M Semrush visits lastest month: 1.02 K

  • Host name: 23.185.0.2
  • IP address: 23.185.0.2
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Kuur Therapeutics" on Search Engine